Keurig
No proof required
Up to $50
13 days left
🔥 505 started this claim
T
Teva Pharmaceuticals
Consumers and entities who purchased QVAR or QVAR Redihaler between January 1, 2015, and July 31, 2025, may be eligible for a share of this $35 million antitrust settlement.
Active settlementSelected statesClaim deadline: July 31, 2026Estimated payout: Varies36 days left
About this settlement
Allegations that Teva engaged in antitrust practices to prevent generic competition for its QVAR asthma medication.
Teva Pharmaceuticals has agreed to a $35 million settlement to resolve claims of antitrust behavior related to its QVAR asthma medication. The settlement benefits individuals and entities who purchased or reimbursed QVAR or QVAR Redihaler within a specified period and in eligible states.
Who qualifies
- Consumers and entities who purchased or reimbursed QVAR or QVAR Redihaler.
- Purchases made between January 1, 2015, and July 31, 2025.
- Purchasers must be residents of the specified states listed in the settlement.
Varies
Claim deadline: July 31, 2026
Silk and Great Value
Proof required
Up to $300,000
113 days left
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
763 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon
Keurig
No proof requiredNew
Up to $50
13 days left
Deadline July 8, 2026
🔥 505 started this claim
View settlement
Silk and Great Value
Proof requiredNew
Up to $300,000
113 days left
Deadline October 16, 2026
View settlement
Audible
No proof requiredNew
Compensation pending
Claims opening soon
Waiting for the claim window
View settlement
Government of Canada
Proof requiredNew
Up to $200,000
763 days left
Deadline July 27, 2028
View settlement